NO20074762L - Identifikasjon av molekylaere diagnostiske markorer for endometriose i blod-lymfocytter - Google Patents

Identifikasjon av molekylaere diagnostiske markorer for endometriose i blod-lymfocytter

Info

Publication number
NO20074762L
NO20074762L NO20074762A NO20074762A NO20074762L NO 20074762 L NO20074762 L NO 20074762L NO 20074762 A NO20074762 A NO 20074762A NO 20074762 A NO20074762 A NO 20074762A NO 20074762 L NO20074762 L NO 20074762L
Authority
NO
Norway
Prior art keywords
endometriosis
identification
value
blood lymphocytes
diagnostic markers
Prior art date
Application number
NO20074762A
Other languages
English (en)
Inventor
Idhaliz Flores
Spyro Mousses
Ester Rozenblum
Original Assignee
Ponce School Of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ponce School Of Medicine filed Critical Ponce School Of Medicine
Publication of NO20074762L publication Critical patent/NO20074762L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

Oppfinnelsen omfatter en fremgangmåte for å identifisere eller predikere predisposisjonen til endometriose i et kvinnelig emne karakterisert ved å bestemme nivået av genuttrykk av minst et differensielt uttrykt gen eller protein eller peptid av perifere blodleukocytter i en prøve av perifere blodleukocytter eller perifert blod i et emne for å gi en første verdi, og bestemme nivået av genuttrykket av minst et differensielt uttrykt gen eller protein eller peptid av leukocyttene i en kontroll eller referansestandard for å gi en andre verdi, og å sammenligne hvorvidt det er en forskjell mellom den første verdien og andre verdien.
NO20074762A 2005-02-18 2007-09-18 Identifikasjon av molekylaere diagnostiske markorer for endometriose i blod-lymfocytter NO20074762L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65433105P 2005-02-18 2005-02-18
PCT/US2005/044723 WO2006091254A1 (en) 2005-02-18 2005-12-09 Identification of molecular diagnostic markers for endometriosis in blood lymphocytes

Publications (1)

Publication Number Publication Date
NO20074762L true NO20074762L (no) 2007-11-16

Family

ID=36182367

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074762A NO20074762L (no) 2005-02-18 2007-09-18 Identifikasjon av molekylaere diagnostiske markorer for endometriose i blod-lymfocytter

Country Status (13)

Country Link
US (1) US20090208939A1 (no)
EP (1) EP1848818A1 (no)
JP (1) JP2008537474A (no)
KR (1) KR20080016789A (no)
CN (1) CN101124340A (no)
AU (1) AU2005327929A1 (no)
BR (1) BRPI0520012A2 (no)
CA (1) CA2596932A1 (no)
IL (1) IL184920A0 (no)
MX (1) MX2007009562A (no)
NO (1) NO20074762L (no)
WO (1) WO2006091254A1 (no)
ZA (1) ZA200707752B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9222938B2 (en) * 2001-12-04 2015-12-29 Michael Tainsky Neoepitope detection of disease using protein arrays
EP2118321A4 (en) * 2007-02-06 2010-06-30 Genizon Biosciences GENCARTS OF HUMAN GENES ASSOCIATED WITH ENDOMETRIOSIS
US8932993B1 (en) 2007-06-11 2015-01-13 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
US11287425B2 (en) 2009-04-22 2022-03-29 Juneau Biosciences, Llc Genetic markers associated with endometriosis and use thereof
WO2009140126A1 (en) * 2008-05-14 2009-11-19 Juneau Biosciences, Llc Method of administering a therapeutic
JP5503942B2 (ja) * 2009-10-30 2014-05-28 シスメックス株式会社 疾患の罹患の判定方法
EP2348129A1 (en) * 2010-01-21 2011-07-27 Sanofi Methods and uses relating to the identification of compound involved in pain as well as methods of diagnosing algesia
KR101333207B1 (ko) * 2011-07-13 2013-11-26 부산대학교 산학협력단 자궁내막증과 연관된 유전자 마커 및 이의 용도
WO2013067451A2 (en) 2011-11-04 2013-05-10 Population Diagnostics Inc. Methods and compositions for diagnosing, prognosing, and treating neurological conditions
EP2812452B1 (en) 2012-02-09 2020-05-27 Population Bio, Inc. Methods and compositions for screening and treating developmental disorders
KR101445560B1 (ko) 2012-05-10 2014-09-29 한국수력원자력 주식회사 저준위 전리방사선에 민감한 유전자 검출 방법 및 상기 방법으로 검출된 유전자
DK2895621T3 (da) 2012-09-14 2020-11-30 Population Bio Inc Fremgangsmåder og sammensætning til diagnosticering, prognose og behandling af neurologiske tilstande
US9434991B2 (en) 2013-03-07 2016-09-06 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
AU2014299322B2 (en) * 2013-06-28 2018-08-09 Acumen Research Laboratories Pte. Ltd. Sepsis biomarkers and uses thereof
EP3511422B1 (en) * 2013-11-12 2022-12-28 Population Bio, Inc. Methods and compositions for diagnosing, prognosing, and treating endometriosis
DE102014203235A1 (de) * 2014-02-24 2015-08-27 Mahle International Gmbh Klimagerät, insbesondere für ein Kraftfahrzeug und Verfahren zur Herstellung einer Komponente eines Klimagerätes
RU2558854C1 (ru) * 2014-06-23 2015-08-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Способ прогнозирования риска развития эндометриоза
JP2016077234A (ja) * 2014-10-17 2016-05-16 国立大学法人鳥取大学 子宮内膜症の早期診断のための診断キット、診断マーカー及び検出方法
CN107326065B (zh) * 2016-04-29 2022-07-29 博尔诚（北京）科技有限公司 一种基因标识物的筛选方法及其应用
CN107858415B (zh) * 2016-09-19 2021-05-28 深圳华大生命科学研究院 用于子宫腺肌症检测的生物标志物组合及其应用
US10240205B2 (en) 2017-02-03 2019-03-26 Population Bio, Inc. Methods for assessing risk of developing a viral disease using a genetic test
WO2019169113A1 (en) * 2018-03-02 2019-09-06 Ponce Medical School Foundation, Inc. Compositions and methods for the treatment of endometriosis
CN108456723A (zh) * 2018-03-21 2018-08-28 福州福瑞医学检验实验室有限公司 一种子宫内膜异位症风险预测的基因检测引物和试剂盒
AU2019255402A1 (en) * 2018-04-20 2020-11-12 The Board Of Regents Of The University Of Texas System Compositions and methods for treating endometriosis
US11906529B1 (en) * 2018-04-27 2024-02-20 Marshall University Research Corporation Methods for treatment and diagnosis of endometriosis
ES2935891T3 (es) 2018-08-08 2023-03-13 Pml Screening Llc Métodos para evaluar el riesgo de desarrollar leucoencefalopatía multifocal progresiva causada por virus de John Cunningham mediante pruebas genéticas

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4401295B2 (ja) * 2002-08-30 2010-01-20 オンコセラピー・サイエンス株式会社 卵巣子宮内膜症の診断法

Also Published As

Publication number Publication date
AU2005327929A1 (en) 2006-08-31
BRPI0520012A2 (pt) 2009-04-14
CA2596932A1 (en) 2006-08-31
WO2006091254A1 (en) 2006-08-31
IL184920A0 (en) 2007-12-03
CN101124340A (zh) 2008-02-13
EP1848818A1 (en) 2007-10-31
ZA200707752B (en) 2010-05-26
KR20080016789A (ko) 2008-02-22
JP2008537474A (ja) 2008-09-18
MX2007009562A (es) 2008-03-11
US20090208939A1 (en) 2009-08-20

Similar Documents

Publication Publication Date Title
NO20074762L (no) Identifikasjon av molekylaere diagnostiske markorer for endometriose i blod-lymfocytter
NO20091572L (no) Biosensorsystem som har forsterket stabilitet og hematokrittytelse
WO2005095644A3 (de) Verfahren zur erkennung von signaturen in komplexen genexpressionsprofilen
EP2287618A3 (en) Method for diagnosing neuro-degenerative disease
WO2008041953A3 (en) Dengue diagnosis and treatment
Belcher et al. Early trends in cystatin C and outcomes in patients with cirrhosis and acute kidney injury
WO2005103719A3 (en) Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignancies
WO2005118403A3 (en) Methods for detecting gene expression in peripheral blood cells and uses thereof
KR102604430B1 (ko) 각막 내피 세포의 기능 부전 진단용 바이오마커
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
Fan et al. Urine proteomics identifies biomarkers for diabetic kidney disease at different stages
US10330682B2 (en) Composition for diagnosing pancreatic cancer and method for diagnosing pancreatic cancer using same
MX2008011665A (es) Diagnóstico y pronóstico de los estados patológicos asociados a la dipeptidil-peptidasa.
Hinkelbein et al. Alterations in cerebral metabolomics and proteomic expression during sepsis
Taylor et al. Aminopeptidase activities as prospective urinary biomarkers for bladder cancer
Kerishnan et al. Identification of biomarkers for periodontal disease using the immunoproteomics approach
Paulo et al. Mass spectrometry-based (GeLC-MS/MS) comparative proteomic analysis of endoscopically (ePFT) collected pancreatic and gastroduodenal fluids
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
US10078086B2 (en) Use of interleukin-27 as a diagnostic biomarker for bacterial infection in critically ill patients
Lopez et al. A pilot study of urinary peptides as biomarkers for intelligence in old age
Tsuchida et al. Application of proteomic technologies to discover and identify biomarkers for periodontal diseases in gingival crevicular fluid: A review
KR20150049989A (ko) 췌장암 진단용 조성물 및 이를 이용한 췌장암 진단방법
KR100999720B1 (ko) 간 경변 진단을 위한 분석방법
Gouin-Thibault et al. Markers of activated coagulation in patients with factor V Leiden and/or G20210A prothrombin gene mutation
US9645150B2 (en) Method for determining the risk of developing brain metastasis, and a kit to carry out said method

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application